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Background: Increasing routine HIV testing among key populations is a public health imperative, so improving
access to acceptable testing options for those in need is a priority. Despite increasing targeted distribution and
uptake of HIV self-sampling kits (SSKs) among men who have sex with men in the UK, little is known about why
targeted SSK interventions for black African users are not as wide-spread or well-used. This paper addresses this key
gap, offering insight into why some groups may be less likely than others to adopt certain types of SSK interventions in
particular contexts. These data were collected during the development phase of a larger study to explore the feasibility
and acceptability of targeted distribution of SSKs to black African people.
Methods: We undertook 6 focus groups with members of the public who self-identified as black African (n = 48),
6 groups with specialists providing HIV and social services to black African people (n = 53), and interviews with
HIV specialist consultants and policy-makers (n = 9). Framework analysis was undertaken, using inductive and
deductive analysis to develop and check themes.
Results: We found three valuable components of targeted SSK interventions for this population: the use of
settings and technologies that increase choice and autonomy; targeted offers of HIV testing that preserve
privacy and do not exacerbate HIV stigma; and ensuring that the specific kit being used (in this case, the TINY
vial) is perceived as simple and reliable.
Conclusions: This unique and rigorous research offers insights into participants’ views on SSK interventions,
offering key considerations when targeting this population.. Given the plethora of HIV testing options, our work
demonstrates that those commissioning and delivering SSK interventions will need to clarify (for users and providers)
how each kit type and intervention design adds value. Most significantly, these findings demonstrate that without a
strong locus of control over their own circumstances and personal information, black African people are less likely to
feel that they can pursue an HIV test that is safe and secure. Thus, where profound social inequalities persist, so will
inequalities in HIV testing uptake – by any means.
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In the UK heterosexuals of black African ethnicity1 are
estimated to be between 20 and 40 times more likely to
have HIV infection than the rest of the national population.
Similarly, with disproportionate diagnoses reported among
non-UK born homosexually active men, we would expect
black African men who have sex with men (MSM) to be
more at risk of HIV than their non-African counterparts
[1]. In addition, black African people are overrepresented
among those who present to UK HIV services with
advanced disease accompanied by the myriad public
health and personal wellbeing implications associated
with delayed presentation [1].
Although a considerable proportion of HIV testing in
the UK is undertaken through sexual health clinics,
these settings tend not to be regularly attended by
black African people [2, 3] and HIV screening in antenatal
services is only accessed by pregnant women. Primary care
services are utilised by black African people, however
opportunities for earlier HIV diagnosis in such settings
are often missed [4]. Historically there have proven to be
many social issues that prevent timely HIV testing among
black African people including concerns about: confi-
dentiality, stigma and discrimination and fear of HIV
diagnosis [5–9]. In addition, wider structural issues can
keep black Africans distanced from HIV prevention,
diagnostic and treatment services. These include, but
are not limited to: poverty, under-employment and lack
of childcare [5] which pose challenges for clinic accessi-
bility; reticence among non-specialists to offer HIV
testing [10, 11], accompanied by a lack of political will
and a lack of African representation in the development
of policy and services [8]. These are issues that have
resonance across the global African diaspora (see for
instance [12, 13]) meaning that this work also has the
potential for international application. Given the increasing
range of innovations in testing approaches and technologies,
this work comes at a crucial time when policy makers and
public health specialists require an up-to-date evidence base
about new options and how they are likely to be perceived
among black African people both in the UK and across the
international African diaspora. By providing a clearer under-
standing of these perceptions, and the specific contexts in
which they arise, it is possible to build an evidence base
for service commissioning and policy that is premised
on empirical evidence, rather than making the assumption
that what works for one key population will be easily
translated for another.
Emergent HIV testing technologies
Emergent HIV testing technologies are often presumed to
have the potential to improve take-up, by circumventing
some of the barriers to testing outlined above (particularly
privacy and stigma), yet technological change will havelittle impact for those who do not perceive the need to
have an HIV test or are fearful of the results in the first
place. Nonetheless, opportunities for improved access to
testing are emerging in the expanded range of HIV testing
options, accompanied by studies of some key population
groups’ perspectives on the increasing availability of
community-based point of care testing and self-sampling
kits (SSKs) in the UK [14–16] and internationally [17–23].
There is considerable optimism that widened access to
HIV testing may increasingly normalise the practice.
Within this context, in April 2014 HIV self-testing
(HIVST) kits became licensed for UK use, although to
date their cost coupled with difficulties monitoring
outcomes for users, means they have not yet been
widely commissioned by the National Health Service
(NHS). In the meantime, both oral and dried blood spot
self-sampling for HIV have been shown to be acceptable
among MSM [18, 24].2 There has been a growing expect-
ation that SSKs will provide an acceptable and feasible
alternative to clinic attendance, which may increase
testing among MSM in the UK [25, 26] as well as among
young men more broadly [27].
This paper reports findings from the development
phase of a larger study which sought to establish whether
embedding both the offer and provision of SSKs within
existing services could also be a cost effective and accept-
able means of increasing HIV testing uptake among all
black African people, by increasing awareness about the
benefits of testing, as well as improved knowledge of the
range of testing choices on offer. A separate output arising
from this study covers methodological rationales as well
as findings across all project phases in greater detail [28].
Prior to this work being initiated, there was little evidence
to support the acceptability or feasibility of targeting
provision of SSKs among black Africans in the UK. One
pilot study run by Terrence Higgins Trust/HIV Prevention
England and Dean Street At-Home has documented
success in reaching black African people through internet
based SSK distribution [29, 30]. Though the study had
greater success in uptake among MSM than black African
people of all sexualities, one phase found that 9.8% of the
7761 SSK requested were by black Africans; 7.3% of which
were returned, with a positivity rate of 2.6% within this
specific sub-group. A systematic literature review under-
taken to inform this wider study demonstrated that there
was a limited body of empirical research undertaken on
the use and perception of SSKs in general [28]. It also
revealed a particular lack of focus upon members of
migrant ethnic minorities which would enable an account
to be given of the particular social contexts that influence
their attitudes and experiences. To our knowledge, our
study presents the first extensive qualitative data on the
perceived appropriateness and feasibility of the offer,
provision and use of SSKs as targeted community HIV
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context of existing services in their country of resettlement.
It therefore has direct utility for those who plan and
commission public health interventions meant to benefit
this population; while also enabling greater reflection on
how these technologies are likely to fit into overarching
public health policy environments.
Methods
The data described here are taken from the formative
development phase of the larger project described and
rationalised briefly above.3 Twelve focus group discussions
(FGDs) and nine one-to-one interviews were undertaken
between September and December 2014 in Glasgow and
London with specialist providers of services to African
people, and groups of black African people not working as
specialist service providers (members of the public,
referred to subsequently as non-specialists). These two
cities reflect areas of divergent HIV prevalence, as well
as different forms of health system infrastructure within
the UK.
Non-specialist FGDs (3 in London/3 in Glasgow)
Purposive sampling captured diversity of gender, age,
region of origin and HIV testing experience. Participants
were recruited via social media and African embassies in
London, as well as among university student groups, and
community based organisations in both cities. Participants
were eligible if they self-identified as being black African
and were aged 18 years and over. Eligibility screening was
undertaken by telephone in order to initiate a relationship
between researcher and participant, and to clarify the aims
and process of data collection.
In order to ensure the facilitation of diverse and salient
perspectives in these group settings, one of the FGDs
was comprised only of people under the age of 30,
another comprised African men only and a further
group was comprised of people with diagnosed HIV. We
did not purposively assemble an African MSM group as
the intervention offers were not based on this parameter.
Also targeted intervention research related to SSKs had
already been undertaken in the UK to benefit MSM of all
ethnicities [26]. In total, 48 self-identifying black Africans
participated, representing a relatively heterogeneous
sample of individuals comprised of 28 men and 20
women; with ages ranging from 18 to 60. Participants
hailed from various regions, including: East Africa (n = 17),
Southern Africa (n = 10), West Africa (n = 10), Central and
North Africa (n = 3) with some born in the UK, Europe or
USA (n = 7, missing = 1)). Our sampling strategy also
ensured that we were able to include the views of
participants who had never tested for HIV (n = 19).
Although we did not screen for sexuality amongst
participants, a minority (approximately 4) made it clearduring the focus group discussion that they were men who
have sex with men. The nature of our varied recruitment
strategy means we are unable to estimate a refusal rate.
Specialist service provider FGDs and interviews (3 in
London/3 in Glasgow)
Purposive sampling was again used to ensure service
providers were from a range of professional backgrounds.
Primary care providers were recruited via the Primary
Care Clinical Research Networks in London and through
established working relationships with members of the
research team. Community workers in both cities were
recruited from organisations with extensive experience of
delivering HIV prevention and care as well as a range of
other non-HIV specific services to black Africans. The
research team approached pharmacies within areas with
high concentrations of African residents in both cities,
with support from local pharmacy associations. Almost all
specialist FGDs comprised those from diverse working
backgrounds in order to elicit contrasts within working
and experiential contexts. One to one interviews with HIV
clinicians, HIV service managers and commissioners were
also conducted.
In total, 53 service providers participated, including:
General Practitioners (GPs) (n = 8), Pharmacists and
Pharmacy Assistants (n = 10), Nurses (n = 3), Health
Care assistants (n = 1), HIV community based organisation
staff (n = 15), other African service providers (n = 5),
African faith leaders (n = 3), HIV consultants (n = 5), as
well as service funders, policy makers and commissioners
(n = 3). There was a fairly even gender split amongst
specialist participants (29 men and 24 women). Using
these varied recruitment methods, it is difficult to report
an accurate refusal rate, although the following refusals
were recorded from amongst our targeted invitations
(community organisations n = 3, general practitioners
n = 3, pharmacists n = 22); and cancellations among those
registered to attend were rare (1 pharmacist and 1 nurse).
Semi-structured topic guides and planned activities
(available at: http://www.haus.org.uk/about/about-haus)
prompted discussion about: accessibility and perspectives
toward HIV testing in general; perspectives on SSKs and
their utility within this population; practicalities and
acceptability of targeted distribution in a range of
community settings used by black African people; and
potential procedures for sample return and clinical
governance. The researchers involved in data collection
(CD, EM, SW, CP, GP and IY) sought to create a balance
between the a priori issues outlined above while also
harnessing participant-led articulation of perspectives,
social norms and discourses [31].
In all focus groups, participants were shown a video
(See Fig. 1) produced by the producers of the TINY Vial
SSK (http://www.tdlpathology.com/test-information/test-
Fig. 1 Stills from corporate instruction video
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instructional video developed by a community organisa-
tion (https://www.youtube.com/watch?v=FSm0zP1TGUo)
on self-use of dried blood spot sampling kits, for contrast
between available self-sampling options. We displayed,
distributed and discussed TINY Vial kits in all groups.
As use of oral fluid kits would not be possible within
the governance structure of our study,4 no oral based kit
was demonstrated during the groups, however, potential
benefits of their use were raised by participants.
Each focus group was run by two expert qualitative
researchers taking it in turns to lead the discussion and
observe/take field notes [32].5 These took place either
on the premises of participating research institutions, orin community based organisations with only the two
researchers and participants present.
In addition, we undertook nine one-to-one interviews
with HIV clinicians, HIV service commissioners and
service managers at their places of work (n = 4 London
and n = 5 Glasgow) in order to ensure data saturation and
also to avoid their presence in focus group discussions
unintentionally suppressing colleagues’ input.
Both the public non-specialist participants and the
specialist service providers attending focus groups were
offered reimbursement for their travel and their time
given to the study. Each interview lasted between 30 and
45 min while the FGDs lasted between one and a half to
2 h. Digital audio recordings of interviews and FGDs
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order to supplement and support the transcripts.
Data analysis and conceptual framework
This work is rooted in an understanding that simply
undertaking interventions to increase knowledge of HIV
and its modes of transmission are insufficient to ensure
uptake of testing among the black African population in
the UK [33]. Alongside information, people need the
motivation as well as the opportunity and capacity to act
in ways that reduce the risk of HIV transmission and
acquisition (including determining one’s HIV status) [34].
In the specific context of timely HIV testing, this means
that people need to feel that having a test is worthwhile,
beneficial and straightforward, and that the act of having a
test in and of itself should not carry negative repercussions.
In structural terms this will require an assured and
confident HIV testing infrastructure in which professional
service providers possess the capacity and confidence to
offer HIV tests to those who are likely to be most at risk of
acquisitions, including black African people. Practical
elements arising from the COM-B model of behaviour
change [35] further supported our data analysis and
planning for subsequent intervention development phases.
It was furthermore essential to acknowledge across the
course of project design, data collection and analysis, that:
a) ‘black African people in the UK’ do not represent a
singular homogenous group, so diverse approaches to
establishing acceptability (as well as approaches to
increasing HIV testing access) were likely to be required;
and b) that the accessibility, uptake and architecture of
HIV testing among black African people in the UK could
only be considered within its wider social, political and
cultural context [8, 36].
Thus, we sought to describe the range of diverse views
and broad commonalities within participants’ discussions
and interviews - focusing on the ways these relate to social
mores, norms and key cultural concerns. Where consider-
able differences between groups were obvious these are
noted and are made explicit.
We used NVivo 10 for overall data management, and
initial thematic analysis was undertaken collaboratively
by seven members of the team (CD, EM, LMcD, PF, GP,
IY, FB) using a Framework approach [37]. We applied
both inductive and deductive approaches, from which
initial themes emerged, including: the feasibility and
accessibility of HIV testing, existing knowledge and
uptake of SSKs, the practicalities of distribution as well
as cross-cutting themes which influenced all of these,
particularly those concerned with trust and HIV-related
stigma. These were then refined to devise a more detailed
participant-led, inductive, thematic framework used for
coding by CD and EM (see Additional file 1 for a detailed
coding tree). Researcher-team discussions and iterativeanalysis focussed upon the internal coherence and face
validity of the resulting analytic structure. Anonymised
quotations are used to illustrate the analysis.
Results
The results are divided into the three key elements of an
integrated intervention to offer SSKs in community
settings, that is: issues arising in targeting SSK offers to
Africans; expanding the range of testing options on offer;
provision of SSKs in ways that manage privacy and HIV
stigma concerns; and the practicalities of using SSKs.
Offering SSKs to Africans
While there was enthusiasm around the abstract notion
of distributing SSKs to disproportionately benefit black
Africans, it is worth noting there may have been some
degree of selection bias within the sample, given that
people were told about the topic of research at the point
of research recruitment.
The SSK was often described by participants as an
important means of bolstering the array of HIV testing
options on offer for black African people.
I like the idea of home sampling because it gives more
choice, flexibility and opportunity for people to have an
HIV test. So for example, if people are worried about
confidentiality, they can do the test in the privacy of
their own home. And even though they still have to send
the result in to a lab, at least it’s not done through a
third person, having to disclose their history and why
they’re worried about HIV. [specialist interview]
Although the kits were certainly not regarded as a
panacea that would be able to resolve all social and prac-
tical barriers to testing in this population, specialists and
non-specialists alike were interested in the extent to
which the SSK offered an opportunity for increasing
individuals’ decision-making about the setting and context
in which they would take a test, perhaps contributing to
improved health autonomy overall. A small number (of
mainly service providers) hoped that widespread availability
of such kits within black African communities might help
to relieve HIV stigma at a deeper, structural level, as they
could help to ‘normalise’ HIV testing. Not everyone agreed,
as it was also mentioned that increasing the extent of
privacy through the use of SSKs may serve to hide HIV
even further away.
A key issue that emerged in relation to making the
offer of SSKs to black Africans was the concern such
behaviour would be perceived to be driven by racism
and discrimination, a matter raised by both specialist
and non-specialist participants as being a reflection of
the problematic power relations in these settings. In
addition to the divisiveness that such an approach might
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service providers undertaking ethnic targeting might do
so simply based on skin colour, and that such an
approach would be complicit with the homogenisation
of highly diverse cultures and communities. Addition-
ally, some participants felt that such judgements could
be based on mis-guided understandings of whether
someone looks ‘black enough’ to be considered as
African. All of these contributions demonstrated partic-
ipants’ recognition of, and concern about, the way that
power imbalance pervades African people’s engagement
with HIV testing (a behaviour that is still considerably
stigmatised in African communities) and with health
services in general. Many African participants (both
specialists and non-specialists) described previous
experiences of racism, being patronised and being
concerned about a lack of fully informed consent in
health settings, and this extended to a concern about
providers’ judgement and communication strategies
when it came to HIV. Having said this, there were also
participants who pointed out that targeting those groups
that the epidemiological data shows to be in greatest need,
is the best use of limited resource:
Participant 1: I have trouble just targeting just Black
communities with that kit, for me it has to be
universal for everyone I wouldn’t like to just target a
specific population group.
Participant 2: This is screening! If the epidemiological
studies that there’re high prevalence and new
incidence rate in that race, in that particular
community, that is really…really where resources
should be. [service provider group]
Some suggestions to help ameliorate potential harm from
targeting included: ensuring that African people are in-
volved in designing and delivering targeted interventions;
‘bundling’ HIV testing in with other ethnically targeted
interventions such as sickle cell and blood pressure
screening; and ensuring that publicly available materials
do not flag up the link between Africans and HIV
prevalence, as this information can be misconstrued
and misused by a wider audience.
Quite apart from the matter of targeting SSKs based
on African ethnicity, were a series of further concerns
about the fact that SSKs may not guarantee African
users the sort of sustained interpersonal engagement
and support traditionally tied to pre- and post-test HIV
counselling. So although this technology had the potential
to offer greater autonomy, flexibility and choice in HIV
testing, worries about the risk of suicidal thoughts and a
potential for self-harm by those who were either waiting
for their results, or being told them by telephone, emergedin a considerable proportion of groups and interviews. In
particular, participants expressed concern about cases
where a user may be informed by telephone of a reactive
result, requiring confirmatory testing in the following
days. Those expressing these safeguarding concerns felt
that being in the physical presence of a professional for
discussion of test results could help to reduce anxiety,
lessen the change of immediate harm, and assure linkage
to support and care services for those with less capacity to
seek these out on their own; and that for these reasons,
SSKs represented a less ‘safe’ option for users.
I mean generally I’m kind of definitely, sort of, pro this
sort of testing but I think that’s something that has to
be thought about that anyone can pick this up and
they might not be in a state of mind where they’re
okay to receive that news. [specialist group]
Comments such as this reveal an underlying concern
that SSKs increase autonomy at the expense of clinical
systems’ control, as these are frequently regarded as the
only means of ensuring extended contact with prevention,
treatment and support services. An assumption is therefore
made that no matter what an individual tester’s preference
for a convenient service, that face to face services (prefera-
bly accompanied with a point of care test with rapid result)
should be deemed to be the superior option. As such, in all
focus group discussions and several interviews there was a
clear preference expressed for the offer and discussion of
HIV testing to always involve direct contact with a highly
skilled specialist provider, with the capacity and resource to
undertake immediate risk assessment followed up by
pre-test counselling and a point of care test (where
appropriate), so that an immediate result could be
delivered within the same consultation event.
I think it's very clinical [referring to the SSK], I personally
would probably rather go to my GP and say here I am.
And also there's something very human about having
somebody…I remember my first HIV test, I was petrified,
I had written my will, I couldn't think about anything
else. I was stressed so how on earth I could have done this
with ten drops of bloods and then post and then label
and then date of birth and then this without help. What
helped that day, there was a nurse who was able to talk
to me. And I didn't feel alone. This [the SSK] was a very
lonely procedure. [specialist group]
Some did recognise that following on from a risk
assessment discussion, a specialist service provider might
come to the realisation that an SSK is the most appropriate
option for a particular individual. However, most held that
it was unlikely to be the most appropriate first-line HIV
testing intervention for most black African people. What
Dodds et al. BMC Public Health  (2018) 18:499 Page 7 of 13most participants made clear is that the ideal HIV testing
intervention is one that assures the availability of face to
face support before, during and after any HIV test that
takes place. The SSK was regarded as a technology that
potentially would make users feel detached from support.
These views are of particular interest given current guid-
ance suggesting a reduced need for pre-test counselling
when HIV testing [38]. To this extent distribution of SSKs
was frequently characterised as being a ‘poor relation’ to
point of care HIV testing.
If you're going to start offering it as an anonymous kind
of thing that's not connected to services, well, what's the
reason for doing that? What problem are you trying to
solve by offering that? [specialist interview]
Right from the outset, then, these findings highlight a
key set of tensions that emerge with screening technolo-
gies which prioritise freedom and autonomy. While
these features are regarded as having potential benefits
in terms of accessibility, what these technologies are
seen to lack is an assurance of immediate access to sup-
port interventions. In addition, participants expressed
concern about the delay in the communication of results
(and the attendant stress that could result), as well as
procedures for communication of results that might lack
clinical robustness. To this extent, many felt that in set-
tings where a trained specialist was already afforded the
space and privacy to introduce HIV testing as an option,
priority should be given to the offer of a point of care
HIV test in such a setting, rather than an SSK.
Provision of SSKs: the primacy of privacy and stigma
avoidance
All participants were clear about the profound challenges
that HIV stigma presents in terms of willingness to engage
in HIV prevention and testing interventions, in the UK just
as much as anywhere else. The implications of this can be
even more profound for those who are marginalised by
uncertain immigration status, precarious or under-
employment, living in a society pervaded by racism and
xenophobia [7]. HIV-related stigma at structural and
interpersonal levels represents a clear challenge to suc-
cessful intervention to promote HIV testing within this
sub-population. It predicates against self-perception of
risk, and even where an individual may overcome this,
it then promotes fear about being seen to access an
HIV testing service, because of the social implications
that may follow.
They rather, you know Africa, we rather die than to
expose ourselves. You understand, we rather… If not
for my pregnancy as [XXX] said, I wouldn't go, I
wouldn't. Do you understand? [non-specialist group]As a result, our analysis revealed a profound (and often
conflicting) set of accounts about the need to afford
privacy in order to discuss and facilitate the undertaking
of HIV testing among black African people. These are by
no means new concepts for the field, but this emergent
technology raises a number of new considerations, par-
ticularly in the way that the demand for privacy emerges
from and potentially impacts upon HIV-related stigma.
For instance, non-specialist participants were highly scep-
tical about offers and distribution of SSKs by community
pharmacists and primary health care practitioners that
would be free of judgment or microagression [39], along-
side concerns that confidentiality might be breached (in
this way, the power dimension emerges again).
As a result, the privacy and confidentiality afforded to
individuals in each potential SSK distribution setting was
the overriding factor that helped participants gauge its
suitability. To make matters more complex, for every
potential SSK distribution setting that was proposed as
having ideal privacy protections by some participants,
others were quick to disagree, by examining a new set of
confidentiality concerns. Therefore, while some saw GPs
as having an ideal combination of privacy and medical
expertise, others worried that Home Office officials
could be notified of an outcome, and there were concerns
that even the discussion of an HIV test could persist on a
medical file with negative consequences.
But for those who have come through that route, there
were also a whole package of concerns about if you
disclose your name and health status, would that
affect the asylum decision. [specialist interview]
While some argued that ordering such a kit to be
delivered through the post at home might be ideal, this
suggestion was almost always vetoed by others who felt
that most black African people in the UK did not live
alone, and the arrival of such a kit in the post (or
even the carrying of a package that is distributed in
the community) would always elicit questions about
what is inside.
The kids can…you know kids, they like playing and
it’s, like…I don’t know, maybe neighbour kids, the
one who reads, is there and stuff. And then he starts,
hey mum, I was next door, I’ve seen this.
[non-specialist group]
These data demonstrate that we cannot underestimate
the extent to which considerations of privacy, and its
limits, are at the centre of considerations for SSK feasi-
bility and acceptability among black African people in
the UK. Our participants were at pains to emphasise that
many in this target population will lack the power to act
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as demonstrated in the comment below.
Another thing that’s comes from, I think, this would
make, raise conflict between, for example, a man, wife
and husband, for example they are, let’s say, an
example of, there are those, kind of, communities, if a
man doesn’t want something, that mean how, a woman
can’t do anything, so, a woman can want to, to just do
the test, but there’s no way, nowhere to hide […] what
about sending it and receiving the, the, the result? […] I
think if the man is okay with what you are doing,
everything in the household is fine, it’s only when the
man is against what, you know, is being, you know, the
information that is being given out at that time, maybe
they say home testing kits, you are watching telly and
automatically the man says, oh, the man says, oh, this is
not going to happen in my house, and with you as a
woman, you want to do it, that’s a no-no in your house,
so, it’s really hard for them. [specialist group]
The prevalence of such issues present considerable
challenges to the introduction of a technology that is
meant to assist in circumventing the problems of low
HIV testing uptake among black Africans. They remind
implementers to be cautious about not introducing new
problems while trying to address existing ones.
At the same time, among the beneficial elements that
participants associated with SSKs, privacy, discretion
and the capacity to determine one’s own status in an
environment of relative anonymity were regarded as
considerable strengths, particularly among those taking
part in non-specialist focus groups. Being able to use a
kit privately was regarded a means of enhancing willing-
ness to test among those who were unlikely to: know
about or use a sexual health clinic, raise HIV in a clinical
setting, or seek out community based testing – which all
relate to the potential for increased autonomy already
discussed above. These mechanisms for achieving increased
privacy through new routes of access to HIV testing were
therefore recognised as ways to help users avoid, or at least
better manage, the widely-perceived stigma which can
discourage many from seeking out an HIV test in the
first place.
[It’s] quite hard for some people to go and approach GPs
or doctors to explain their situation. Like myself, I've
been thinking about it. It's been in my mind for a long
time to do a test, because I've been hearing people, I've
been watching this, I've been… you know what I mean,
media’s talking about it, so I don’t even know my status,
but when something like this came up, if it's, like you
said, I think it's an opportunity for people like me to
take the chance to do it. [non-specialist group]Interventions that increase knowledge of SSKs (by
introducing them in embedded services) and demon-
strate their convenience (particularly if introduced sensi-
tively by skilled service providers) were therefore hailed
by some as increasing the likelihood of HIV testing
among Africans.
… especially with location, where people live, they
don’t have that time to go to the hospital and go
through the whole process of getting a HIV test.
[non-specialist group]
At the same time, there was also some concern
expressed that this extended privacy meant SSKs might
contribute unwittingly to ‘keeping HIV underground’,
providing cover to those who desired secretive means of
confirming whether or not they are infected.Practicalities of using HIV SSKs
Most non-specialist participants were unaware of SSKs
prior to taking part in this research, and only a handful
disclosed having used one in the past – so existing levels
of knowledge were low. Some had heard of instant result
self-testing, as there were national media reports about
that technology being licenced just before the period of
research; and a sub-set of these were then surprised to
learn of the requirement to take a sample, post a vial of
blood and await laboratory results. Participants were
surprised at the volume of blood (400 μl) required for a
sufficient TINY Vial sample. In particular, many specialist
providers stressed that they did not think that most black
African members of the public would be able to produce
enough volume for a viable sample – so there was concern
about the way the demands of this kit might influence
willingness to use it.
I mean, we do health checks and we take blood from
the finger and our machines just been changed to take
a much smaller sample, we have to take 40 microns of
the blood, not a big amount which is why I kind of, I
was a bit shocked at this. And just getting that
amount of blood is actually sometimes quite traumatic
for a person. [specialist group]
In addition to discussion about fear of needles and
blood inhibiting self-sampling, a few pharmacists, nurses
and GPs held the view that physiologically, their black
patients may have difficulty producing fingerprick
samples because of a perception that they would have
thickened skin on the fingertips.
Many participants across all focus groups felt that for
these reasons, as well as complexities of using, labelling
and sending the sample in a vial, the requirements of the
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correctly – and some might just give up on it before
they even begin, due to perceived complexity.
I think that will be quite tricky. Certainly, I don't think
it’s one that you can tell them it’s that easy to do […]
maybe if the test was simpler. [specialist group]
Can I be very honest? I don’t like this, and the reasons
why I don’t like it is because it isn’t simple… It isn’t
easy and, of course, this will not be popular. I think
this is an attempt to make people laboratory people.
By the time people put a jab and then put their hands
and blood starts dripping, one, two, three, four, five,
six, seven, eight, up to 20, I find it a bit… very, very
cumbersome. It makes it very, very… It’s liable to a lot
of mistakes. And so what do you then do?
[non-specialist group]
Furthermore, a number of participants expressed
concern that SSKs could be easily contaminated by
users, perhaps by touching the top of the vial or the lid,
or not cleaning the puncture site sufficiently. Others
questioned the robustness of the technology and procedures
on offer to the public, and felt users may worry about
samples being mismatched at the laboratory. So there
were issues with a lack of trust over direct engagement
with providers of laboratory services. A few specialists and
non-specialists also conveyed an (erroneous) concern that
unskilled users might cause onward transmission through
a blood spill.
In many of the discussions with specialists, they raised
comparisons between these HIV SSKs and a range of
kits for other conditions that are now designed for self-
sampling. These comparisons highlighted that a range of
kits intended for self-sampling had not been a great
success (chlamydia and bowel screening kits in particular
were perceived as under-used and not cost effective). In
contrast, HIV specialist providers with experience using
dried blood spot kits for HIV self-sampling among MSM
were encouraged by the benefits that self-sampling could
bring to African users.
Discussion
These findings reveal that despite the clear sense that
SSKs may increase access to HIV testing among African
people in the UK, that both users and providers were
cautious about the value they would really add to the
current testing landscape, given their concern that SSK
provision involves a low level of interaction with those
who can provide specialist advice and support through-
out the testing process. Such perspectives are connected
with the view that all people accessing HIV testing (and
in particular, black Africans in this instance) need tohave a strong locus of control over their own informa-
tion alongside the practicalities of kit use – and that
many SSK processes would need strengthening in order
to secure confidence and acceptability within this popu-
lation. Also this study again raises a number of concerns
from both providers and potential users, that the offer of
SSKs in way that is intended to disproportionately benefit
African people in community settings needs to be under-
taken with considerable sensitivity to the HIV stigma that
such targeting may exacerbate. This discussion section
considers these issues in light of health behaviour change
models as a means of considering how best to design
targeted SSK interventions that are acceptable and feasible
among black Africans.
In almost all current models of health behaviour
change and models for influencing health it is recog-
nised that the social ecology plays a significant part in
enabling the desired behaviour to take place. The model
that underpins this paper holds that people require
knowledge, will and power to ensure their HIV preven-
tion and testing needs are best met – and these have
each been flagged throughout the presentation of the
findings above [34] (also see [40, 41]). In this final
section, we will consider how, in the case of SSKs, these
three factors are likely to combine to influence decision-
making and support action. Where there is a deficit in
one area, the other two are necessarily diminished, and
conversely, there any one of these factors is increased it
improves the likelihood that the other factors will also
be improved.
In the context of this work, knowledge relates to:
awareness of a range of HIV testing options, information
that enables a person to accurately assess their own
HIV risk over the course of a lifetime, and knowledge
of HIV transmission basics. This research project was
not designed to assess the degree of such forms of
knowledge at a community level, and there are other
data sources that provide insights into this set of knowledge
among this population [42]. In terms of the specific
knowledge needs related to SSKs, despite their avail-
ability in the UK for a number of years, most specialists
and non-specialists alike had no prior awareness of
their availability or use. If there is a desire to increase
uptake of this option among black African people, there is
an acute need to improve information about availability
for this population and those who provide them with
services. To this extent the way in which the kits are
offered will be key to helping to improve the knowledge
base about their existence and utility.
When referring to will in this conceptual framework,
we are referring to the perceived benefits and costs of a
range of behaviour options and their alternates. Within
this process of weighing up benefits and costs, each individ-
ual’s tipping point (within each instance of a decision being
Dodds et al. BMC Public Health  (2018) 18:499 Page 10 of 13made anew) will vary depending on how much importance
they place on the potential benefits, as opposed to how
much significance they accord the potential harms. In many
instances, this process is profoundly influenced by what we
think is acceptable and important to those who are signifi-
cant to us, by what we think our significant others would
do in the same situation, and by how much we want to
conform with our significant others [41]. Below we discuss
a range of the findings described above in light of the way
that they could influence willingness to use an SSK when
offered it.
The issue of HIV-related stigma, and whether people
had the skill, capacity and will to tackle it was perhaps
the most influential determinant of the way they
regarded the feasibility of uptake of these kits among
black Africans. For some, the privacy and autonomy
afforded by such kits made it a highly acceptable and
worthwhile option, while for others the social risks asso-
ciated with even being known to accept or carry such a
kit were seen as an ongoing barrier to uptake. Concerns
about what significant others (and even strangers) might
think about a person who needed an HIV SSK were at
the centre of most discussions.
At an infrastructure level, data from specialist partici-
pants also made it clear that there remains an ongoing
tension between the desire to provide an increased range
of HIV testing options to people with the greatest likelihood
of undiagnosed HIV, while at the same time a concern that
the further away from clinics that such technologies
venture, the less ‘systems control’ that can be exercised
over the outcome. These tensions between increasing
autonomy at the cost of ensuring a singular and reliable
pathway into HIV care are likely to have considerable
impact on the willingness of specialist providers to
make SSKs available to those most in need. Furthermore,
health providers who do not specialise in HIV expressed
particular concern about being perceived as racist if they
target their African patients for HIV testing, and so an
unwillingness to target SSK distribution to some
subgroups in greatest need (for fear of the harmful
repercussions) is clearly a further issue to be addressed.
A final point to make about willingness to use the SSKs
relates to the direct concern that the TINY vials would
be too difficult to use, and that the volume of blood
required would be off-putting to many people.
Finally, in order to act on any intention to undertake a
health-related behaviour, people need to have the necessary
material resources, skills and opportunities which offer
them the capacity to make a free choice. Without this
power, knowledge and will - on their own - are insufficient.
The findings described above demonstrate the myriad of
ways in which HIV-related stigma impacts on people’s
capacity to act, particularly when they lack control in other
areas of their life. Whether it is inequality within sexualrelationships, or concerns about deportation that may
cause people to fear the act of finding out their HIV status
(or what might happen if the result was positive), there
were many times that participants pointed to the range of
social vulnerabilities experienced by black African people
which prevents them from confronting their own HIV risk.
There were also those who were strongly of the opinion
that at least for some people, SSKs represented a possibility
for liberation from these norms, because it shifted the
locus of control over privacy, timing and results manage-
ment towards the individual. Of course, such an approach
was not regarded as being risk-free, but on balance, some
participants regarded the benefits as greatly outweighing
the potential harms. Yet others felt that this gain could be
outweighed by those cases where vulnerable individuals
might feel trapped, alone and powerless while waiting to
hear of their result, and that telephone support in such a
context was insufficient.
It is clear that in order to gain a reasonable foothold
amongst the array of HIV testing options currently on
offer, SSK interventions will need to better demonstrate
how they add value (which could potentially include
greater focus on distribution in settings where distribu-
tor expertise and/or privacy are minimal). In addition,
those planning such interventions will need to take
serious account of the implications of these findings as
they seek to improve the knowledge, will and power of
black African people in the UK who need to establish
their HIV status.
Limitations
These qualitative findings do not make a claim to broad
generalisability, however, they were sufficient to enable
the study team to take account of key issues in develop-
ing the protocol for the second phase of the larger study.
Additionally, given the governance constraints of the
research environment, we were not able to explore other
SSK options (such as dried blood-spot kits, or those
using oral saliva samples) in much detail within this
study. This is because the TINY vial is the only SSK
device and assay that is CE approved in the UK. We
were unable to locate a service provider willing to
accept the liability of proceeding with using a product
off-license.
This means that participants’ views on SSKs were
heavily influenced by their impressions of the TINY vial
kit itself, and some of these issues could have been
ameliorated or altered if they had been asked to con-
sider other self-sampling technologies as comparators,
for instance. Nonetheless, this paper has focused on a
range of generic issues related to SSKs that would apply
no matter what device or technology was used, including
discussions about privacy, communication of results and
HIV-related stigma. It is also worth noting that all
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ments, and it is possible that those in more rural or semi-
rural locations might have different perspectives to bear
on the utility of SSKs.
Conclusion
These findings reveal that despite some general initial
enthusiasm, SSK use and targeted distribution among
black African service users and their providers in the
UK is likely to be greeted with considerable ambivalence.
Having undertaken the first in-depth study to explore
the feasibility and acceptability of targeted distribution
of these kits to black African people accessing existing
services, we have found that although an improvement
in the variety of HIV testing options is welcomed, this
technology will not be a panacea for the range of issues
that prevent timely testing, nor will it usually be preferable
to face to face rapid testing with immediate opportunity
for referral. We have collated an extensive range of
specialist and non-specialist perspectives, subjecting these
to rigorous thematic analysis in order to better understand
how SSKs can be put to best use for this community.
Policy makers, public health specialists and commis-
sioners of HIV testing services require these insights to
guide their decision-making on HIV testing options in
the future. Furthermore, we expect those examining
potential HIV testing technologies for use among the
African diaspora in other high-income countries may
find resonance with this work. Clinical practitioners
and community organisations will also find that the
themes of privacy, dignity and locus of control are
worth exploring further before instigating their own
targeted services for migrant groups.
Endnotes
1The term ‘Black African’ appears as an ethnic category
in the UK Census, and is widely used in UK epidemiological
contexts to denote those who are part of the sub-Saharan
African diaspora. It can be used to refer to people who have
themselves migrated from this region, or whose predeces-
sors have done so. This is also a highly contested and
imprecise term, as it relates at one and the same time to
self-identification as well as external-identification of racial/
regional categories which are far from straightforward, and
which also intersect with nationalities as well as linguistic
and cultural groupings.
2HIV SSKs are designed for users to take their own
sample and then post it to the laboratory themselves.
Results are then usually communicated to the user via
either SMS text (where results are negative) or by a
phone call (where there was an insufficient sample or a
reactive result). In UK settings, clinical governance over
laboratory procedures, and results communication is
overseen by those working in expert clinical settings,and where a sample is reactive, sufficient information is
given to the user to encourage them to attend their
nearest clinic as soon as possible for confirmatory
venous sample testing. While HIV SSKs can use either
blood or oral fluids, only the blood based TINY vial and
associated laboratory assay is CE Marked for approved
use in the UK; also no oral SSK is currently able to
provide 4th generation testing as recommended by the
British HIV Association guidelines.
3More detail is available at: http://haus.org.uk/about/
about-haus; with a full trial protocol available at: https://
njl-admin.nihr.ac.uk/document/download/2007197
4Given that there is currently no CE marked saliva-
based HIV assay available in the UK, the study team was
not permitted this type of ‘off label’ use.
5CD, EM, SW, CP, GP and IY (all female Research Fel-
lows / Lecturers with PhDs in medical sociology, social
epidemiology or allied disciplines) conducted the data
collection. All have considerable experience and training
in the collection, management and analysis of qualitative
data. Most members of the team also had considerable
experience in the HIV field.
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